Zealand Pharma As Stock Short Ratio
Zealand Pharma AS fundamentals help investors to digest information that contributes to Zealand Pharma's financial success or failures. It also enables traders to predict the movement of Zealand Stock. The fundamental analysis module provides a way to measure Zealand Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zealand Pharma stock.
Zealand |
Zealand Pharma AS Company Short Ratio Analysis
Zealand Pharma's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Zealand Pharma Short Ratio | 37.96 X |
Most of Zealand Pharma's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zealand Pharma AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Zealand Pharma AS has a Short Ratio of 37.96 times. This is much higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The short ratio for all United States stocks is notably lower than that of the firm.
Zealand Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zealand Pharma's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zealand Pharma could also be used in its relative valuation, which is a method of valuing Zealand Pharma by comparing valuation metrics of similar companies.Zealand Pharma is currently under evaluation in short ratio category among its peers.
Zealand Fundamentals
| Return On Equity | -1.15 | |||
| Return On Asset | -0.38 | |||
| Operating Margin | (3.28) % | |||
| Current Valuation | 1.32 B | |||
| Shares Outstanding | 46.12 M | |||
| Shares Owned By Institutions | 1.74 % | |||
| Number Of Shares Shorted | 75.47 K | |||
| Price To Earning | 10.49 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 2.77 X | |||
| Revenue | 292.57 M | |||
| Gross Profit | 173.75 M | |||
| EBITDA | (982.6 M) | |||
| Net Income | (1.02 B) | |||
| Cash And Equivalents | 1.12 B | |||
| Cash Per Share | 25.99 X | |||
| Total Debt | 647.91 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 4.79 X | |||
| Book Value Per Share | 10.91 X | |||
| Cash Flow From Operations | (1.21 B) | |||
| Short Ratio | 37.96 X | |||
| Earnings Per Share | (3.26) X | |||
| Target Price | 240.78 | |||
| Number Of Employees | 237 | |||
| Beta | 1.34 | |||
| Market Capitalization | 814.14 M | |||
| Total Asset | 2.07 B | |||
| Net Asset | 2.07 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Zealand Stock
If you are still planning to invest in Zealand Pharma AS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zealand Pharma's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |